0001801385-24-000002.txt : 20240124 0001801385-24-000002.hdr.sgml : 20240124 20240124174440 ACCESSION NUMBER: 0001801385-24-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240122 FILED AS OF DATE: 20240124 DATE AS OF CHANGE: 20240124 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Romano Kathryn CENTRAL INDEX KEY: 0001801385 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38210 FILM NUMBER: 24558003 MAIL ADDRESS: STREET 1: C/O KRYSTAL BIOTECH, INC. STREET 2: 2100 WHARTON STREET, SUITE 701 CITY: PITTSBURGH STATE: PA ZIP: 15203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Krystal Biotech, Inc. CENTRAL INDEX KEY: 0001711279 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 821080209 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2100 WHARTON STREET STREET 2: SUITE 701 CITY: PITTSBURGH STATE: PA ZIP: 15203 BUSINESS PHONE: (412) 586-5830 MAIL ADDRESS: STREET 1: 2100 WHARTON STREET STREET 2: SUITE 701 CITY: PITTSBURGH STATE: PA ZIP: 15203 4 1 wk-form4_1706136270.xml FORM 4 X0508 4 2024-01-22 0 0001711279 Krystal Biotech, Inc. KRYS 0001801385 Romano Kathryn C/O KRYSTAL BIOTECH, INC. 2100 WHARTON STREET, SUITE 701 PITTSBURGH PA 15203 0 1 0 0 Chief Accounting Officer 1 Common Stock 2024-01-22 4 M 0 2500 52.26 A 15056 D Common Stock 2024-01-22 4 S 0 2500 130 D 12556 D Stock Option (Right to Buy) 52.26 2024-01-22 2024-01-22 4 M 0 2500 0 D 2030-01-30 Common Stock 2500 10000 D The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on August 29, 2023 and will terminate on June 28, 2024 and contemplates option exercises and sales of 2,500 shares with a limit price of $130.00 per share. The transaction was executed in one trade. 50,000 options were granted that vest in four equal annual installments beginning on January 20, 2021. /s/ Kathryn Romano 2024-01-24